"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

The same business leaders who are publicly cordial to Donald Trump—even to his face—privately bemoan the havoc the ...

CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

A much-anticipated meeting between President Donald Trump and representatives of the pharmaceutical industry took place ...

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...